Diabetic Neuropathic Pain
Reimbursement: Receive reimbursement for your time and commitment to the study plus travel expenses or transport will be provided.
About This clinical research study
MAC Clinical Research is currently conducting a trial to test a potential new treatment for diabetic neuropathic pain (DNP). Neuropathic pain is present in 7-10% of the general population and symptoms of DNP often include a burning, stabbing, prickling, or aching sensation in the legs or feet, which is chronic and difficult to manage. The condition carries a substantial physical, social, and economic burden.
The trial medication aims to assess the safety and first signs of pain relief experienced in patients with diabetic neuropathic pain. The medication is believed to have the potential to reduce the inflammation that triggers diabetic neuropathic pain and improve quality of life for patients.
Reimbursement: Receive reimbursement for your time and commitment to the study plus travel expenses or transport will be provided.
Clinics
Greater Manchester and Teesside
Therapy Area
Diabetic Neuropathic Pain
Gender and Age
Males and Females aged 18 +
A full description of the study will be given before you decide to take part, both over the phone and during an appointment at a MAC clinic. This will include you receiving the full patient information sheet (PIS). Your GP will also be notified of your participation.
If you contact us, it does not mean you have to decide at that point whether to participate.
If you do decide to participate you are free to withdraw at any time.
The medication or placebo will be taken orally once daily, in the form of 3 tablets over a period of 11 weeks. The complete trial period will last for 16 weeks. The trial medication is being developed to address the existing significant unmet medical need for more effective treatment with better safety/tolerability.
Reimbursement: Receive reimbursement for your time and commitment to the study plus travel expenses or transport will be provided.
Key Inclusion Criteria
- Men and Women at least 18 years of age
- Type 1 or type 2 Diabetes
- Have diabetic neuropathic pain for at least 6 months prior to the screening
- Participant should be on stable antidiabetic treatment for at least 3 months prior to the screening
- Women of childbearing potential and male participants of reproductive potential must agree to use highly effective birth control methods
Key Exclusion Criteria
- Significant cardiovascular or cerebrovascular disease, including stroke, mini-stroke and heart attack in the last 3 months
- Major depressive episode within last 6 months
- Uncontrolled high blood pressure within last 3 months
Other eligibility criteria will apply. Please contact MAC for more information.
If you are eligible you will receive a comprehensive health screen. Your GP will be fully informed of your participation and provided with any information relevant to your healthcare.
ABOUT CLINICAL RESEARCH STUDIES
Clinical research studies are performed as a way of bringing about progress in medicine and research. Clinical research studies make it possible to scientifically assess the properties of a drug, to demonstrate the effectiveness and safety of a treatment or a medical device, or to learn more about a disease and methods to diagnose and monitor it.
If the study is successful, it may be an important step towards developing a promising new treatment.
MAC Clinical Research is currently conducting a trial to test a new potential treatment for diabetic neuropathic pain.
If you would like more information, please fill in the form below and we will be in touch…
Alternatively, please call our recruitment team on freephone 0800 633 5507.
Know someone who may be interested in taking part? Share this page here:
